Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2000
04/19/2000EP0788479B1 Substituted phthalimido-cinnamic acid derivatives with herbicidal effect
04/19/2000CN1250768A Process for preparing anthracene, phenanthrene and karbazole
04/19/2000CN1051551C Novel pyrrolocarbazoles derivatives
04/19/2000CN1051452C Application of 3-substituted aryl oxidized indole compounds
04/18/2000US6051719 Dibenzorhodamine dyes
04/18/2000US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics
04/18/2000US6051593 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
04/18/2000US6051588 Which have significantly reduced gastrointestinal side effects
04/18/2000US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions
04/18/2000US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
04/18/2000US6051561 Compounds and compositions for delivering active agents
04/13/2000WO2000020388A1 Indolin derivatives as sun protection agents
04/13/2000WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators
04/13/2000WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
04/13/2000WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
04/13/2000DE19842416A1 Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden Secondary amines for the prevention and treatment of diseases that are caused or aggravated by oxidation processes
04/13/2000CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
04/12/2000EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
04/12/2000EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect
04/12/2000EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/12/2000EP0991619A1 INHIBITORS OF $g(a) 4?$g(b) 1?MEDIATED CELL ADHESION
04/12/2000CN1051311C N-heteroaryl-n'-phenylurea derivatives, their production and use
04/12/2000CN1051303C Cyclopentadiene derivatives, its producing process and use,and lubricant or fuel oil composition and concentrate containing the same
04/12/2000CN1051302C 3-(indol-3-yL) propenoic acid derivatives and as NMDA antagonists
04/12/2000CN1051301C Indoloylguanidine derivatives, its pharmaceutical composition and use
04/11/2000US6049428 Coating a substrate with a solution of an organic dye occurring in the lyotropic liquid-crystal state in a solvent while simultaneously orienting the dye and removing the solvent
04/11/2000US6049018 As alkylation catalyst for alkylation of aromatic hydrocarbons
04/11/2000US6048986 Dehydration of difluoropyromellitic acid to form difluoropyromellitic dianhydride
04/11/2000US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders
04/11/2000US6048858 Heteroring containing a sulfonamide group
04/11/2000US6048852 Bactericides
04/11/2000US6048637 Nonaqueous secondary battery
04/06/2000WO2000018767A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000WO2000018735A1 2-substituted heterocyclic sulfonamides
04/06/2000WO2000018734A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
04/06/2000WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
04/06/2000WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
04/06/2000WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO2000018708A1 Transfer hydrogenation process
04/06/2000WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
04/06/2000CA2345944A1 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000CA2342622A1 New substituted indolinones,their preparation and their use as medicaments
04/05/2000EP0990641A1 Process for the synthesis of alpha-substituted ring systems
04/05/2000EP0990637A1 Process for producing ketoprofen and 5-benzoyl-3-methyl-2-indolinone
04/05/2000EP0989973A1 Chalcones having antiproliferative activity
04/05/2000EP0785923B1 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/05/2000CN1249756A Metallocenes and catalysts for olefin-polymerisation
04/05/2000CN1249742A Anti-inflammatory compounds
04/04/2000US6046361 Polyorganofullerenes
04/04/2000US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors
04/04/2000US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors
04/04/2000US6046138 For inducing root formation in a broad range of plants; efficiency
04/04/2000US6045398 Battery accepting unit and battery pack
04/04/2000CA2204739C Macrocyclic lactone compounds and their production process
04/04/2000CA2105402C Radiolabelled compound formulations
03/2000
03/30/2000WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
03/30/2000WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof
03/30/2000WO2000016810A1 Near infrared fluorescent contrast agent and fluorescence imaging
03/30/2000DE19844003A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents e.g. for treating viral infections, tumors, inflammation or autoimmune disease
03/30/2000CA2413033A1 Near infrared fluorescent contrast agent and fluorescence imaging
03/30/2000CA2344412A1 Thiol compound, their production and use
03/30/2000CA2344315A1 Near infrared fluorescent contrast agent and fluorescence imaging
03/30/2000CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity
03/29/2000EP0989128A1 4-Hydroxyindoles kationic and their use for oxidation dyeing of keratinous fibres
03/29/2000EP0989119A1 Process and intermediates for preparing trovafloxacin acid salts
03/29/2000EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
03/29/2000EP0988057A1 Drug targeting
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0988034A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
03/29/2000EP0987997A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
03/29/2000CN1248973A Oxazolidines as 5-HT2A-antagonists
03/29/2000CN1248972A Cycloimido-substituted benzofused heterocyclic herbicides
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248580A Process for preparing monacid salt of tonorfloxacin
03/29/2000CN1248577A Novel cation type 4-oxyindole, its oxidation dyeing, dyeing composition and dyeing method for keration fibre
03/29/2000CN1248435A Keratin fibre dyeing composition using cation direct dye and thickening polymer
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/28/2000US6043393 By reacting carboxamides, olefins, alkylmagnesium halides or zinc alkyl compounds, and orthometallates of given formula; regioselective, fast and cost effective synthesis; useful for various bioactivities
03/28/2000US6043390 Useful for the intracellular delivery of polynucleotides; cationic lipids useful in the preparation of liposomes and other lipid vesicles for the delivery of nucleic acids into mammalian cells
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043270 Antiinflammatory agents
03/28/2000US6043264 Benzene-condensed heterocyclic derivatives and their uses
03/28/2000US6043257 Amidinoindoles, amidinoazoles, and analogs thereof
03/28/2000US6043247 Modulators of molecules with phosphotyrosine recognition units
03/28/2000US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
03/28/2000US6043232 Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
03/28/2000US6042814 Sulphonic acids and their use as UV absorbers
03/28/2000CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
03/23/2000WO2000015657A1 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and 53
03/23/2000WO2000015634A2 Hiv protease inhibitors
03/23/2000WO2000015633A1 Condensed heterocylic compounds and herbicides containing them
03/23/2000WO2000015612A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000WO2000015603A1 Benzene derivatives and medicinal use thereof
03/23/2000WO2000015206A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1998015272A8 Method for inhibiting stress-activated protein kinases
03/23/2000CA2343101A1 Benzene derivatives and medicinal use thereof
03/23/2000CA2343017A1 Condensed heterocylic compounds and herbicides containing them
03/23/2000CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors